The Toxic Effects of Phenylbutazone (Butazolidin)
- 8 September 1955
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 253 (10) , 404-410
- https://doi.org/10.1056/nejm195509082531003
Abstract
DRUGS employed in the past and at present for the relief of pain in the various forms of arthritis carry with them noxious traits that limit or prevent their use. Cincophen was abandoned because of its adverse effects on the liver. Cortisone has been responsible for serious side reactions, which have been limited by professional and public awareness of this drug's unwanted effects. Toxic reactions from gold have been held within bounds because it cannot be self-administered. Aminopyrine is no longer used because of its disastrous effects on the bone marrow. Today, phenylbutazone (Butazolidin), chemically similar to aminopyrine, is in . . .Keywords
This publication has 54 references indexed in Scilit:
- Fatal Agranulocytosis following PhenylbutazoneBMJ, 1954
- Stevens--Johnson Syndrome and Granulocytopenia after PhenylbutazoneBMJ, 1954
- Death from Hypersensitivity due to PhenylbutazoneBMJ, 1954
- PHENYLBUTAZONEThe Lancet, 1953
- "Butazolidin"BMJ, 1953
- BUTAZOLIDINEThe Lancet, 1953
- Medico-LegalBMJ, 1952
- BUTAZOLIDINEThe Lancet, 1952
- BUTAZOLIDINEThe Lancet, 1952
- BUTAZOLIDINEThe Lancet, 1952